Glabellar wrinkle filler: rejuvenation for lines between the eyebrows

KEIT Day Hospital has clinical facilities dedicated to aesthetic medicine treatments, organised to ensure appropriate standards of hygiene, procedural precision and patient comfort.
For glabellar wrinkle treatment, the doctor assesses the depth of the folds, muscle contraction and the anatomical characteristics of the region between the eyebrows. When clinically appropriate, filler treatment is performed using sterile, single-use instruments and materials selected according to the procedure.
The organisation of the clinical facilities and the availability of medical resources allow the different stages of treatment to be managed, from skin preparation to observation immediately after the procedure.

KEIT Day Hospital works with medical professionals experienced in aesthetic medicine, injectable techniques and facial anatomy. In glabellar wrinkle treatment, knowledge of muscular structures and the course of the supratrochlear and supraorbital arteries is essential for assessing the risks associated with injections.
The procedure is considered according to the patient's individual characteristics, distinguishing dynamic wrinkles from static wrinkles and assessing the possibility of using botulinum toxin or other alternatives to fillers.
An additional advantage is the presence of a multidisciplinary medical team within KEIT Day Hospital, allowing specialists in anaesthesia and intensive care or other medical disciplines to be involved when additional assessments or specific medical assistance are required.

Before glabellar wrinkle treatment, the doctor carries out an individual assessment of wrinkle depth, muscle activity, skin quality and the patient's expectations. The consultation includes taking a medical history, with particular attention to allergies, medications being taken, previous aesthetic treatments, skin infections and possible contraindications.
Assessment of the glabella, both at rest and during facial expressions, makes it possible to distinguish wrinkles caused by muscle contraction from those that remain visible at rest. Because this region carries a high vascular risk, fillers are not automatically the most appropriate solution. The doctor assesses the balance between benefits and risks and discusses possible treatment alternatives.

KEIT Day Hospital follows hygiene and infection prevention protocols that include disinfecting clinical areas, skin antisepsis and the use of sterile, single-use devices during injectable treatments. Particular attention is paid to skin preparation, instrument handling and checking the packaging of the products used.
When a hyaluronic acid filler is considered, the choice of preparation must comply with its approved indications and the anatomical characteristics of the area. Each product used is identified by its brand name, batch number and traceability information, which are recorded in the patient's clinical documentation.

Glabellar wrinkle filler treatment requires particular caution because the glabella is a region with a high vascular risk. In addition to temporary effects such as swelling, redness or bruising, rare but serious complications may occur, including vascular occlusion, skin necrosis and permanent loss of vision.
Prompt recognition of symptoms and activation of emergency protocols are essential. Management of suspected vascular occlusion caused by hyaluronic acid may include the use of hyaluronidase when indicated, while any visual disturbances require immediate specialist medical attention.
One of KEIT Day Hospital's distinguishing features is the availability of hospital infrastructure and a multidisciplinary medical team. The facility has three equipped operating theatres, specialists in anaesthesia and intensive care, equipment for monitoring vital signs, emergency management devices and a postoperative recovery room. These resources provide additional medical support, alongside the specific protocols required to manage complications associated with injectable treatments.

At KEIT Day Hospital, patient care continues after glabellar wrinkle treatment has been completed. Patients receive personalised instructions on precautions to follow, temporary effects that may occur and warning signs requiring immediate medical assessment.
When filler treatment is performed, follow-up is determined according to the patient's individual response. A follow-up appointment after approximately 10–14 days, when indicated, allows the doctor to assess the result once the initial swelling has subsided, checking symmetry, the depth of any remaining wrinkles and possible irregularities. Severe pain, changes in skin colour or visual disturbances require urgent medical attention.
For international patients, care may also continue remotely through communication with medical staff and guidance on necessary follow-up appointments. KEIT Day Hospital also provides an emergency contact number, available 24 hours a day, 7 days a week.

KEIT Day Hospital places particular emphasis on transparent information and treatment documentation. Before any glabellar wrinkle filler treatment, patients receive explanations about the selected product, available alternatives, expected benefits, the estimated duration of results and potential risks, including serious vascular complications.
Clinical documentation records the filler's brand name, batch number, quantity administered and injection sites, ensuring traceability of the procedure. When appropriate and with the patient's consent, photographic documentation is taken to compare the initial appearance with the treatment result. The informed consent form, treatment quotation and administrative documentation also allow patients to understand the clinical and financial aspects of the procedure before undergoing treatment.